Publicaciones en colaboración con investigadores/as de GlaxoSmithKline (Spain) (30)

2008

  1. Cidal activity of oral third-generation cephalosporins against Streptococcus pneumoniae in relation to cefotaxime intrinsic activity

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 27, Núm. 8, pp. 679-683

  2. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 27, Núm. 1, pp. 75-80

  3. β-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: An in vitro pharmacodynamic simulation

    Chemotherapy, Vol. 54, Núm. 2, pp. 84-90

2007

  1. Levofloxacin vs. azithromycin pharmacodynamic activity against S. pneumoniae and H. influenzae with decreased susceptibility to amoxicillin/clavulanic acid

    Journal of Chemotherapy, Vol. 19, Núm. 6, pp. 670-672

2005

  1. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point

    International Journal of Antimicrobial Agents, Vol. 25, Núm. 2, pp. 163-167

  2. Optimización farmacodinámica de la administración de ceftazidima frente a Pseudomonas aeruginosa: ¿Infusión continua o administración intermitente?

    Revista Espanola de Quimioterapia, Vol. 18, Núm. 1, pp. 21-25

  3. Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs Differ

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 3, pp. 996-1001

  4. Situación de la cefalosporina oral de tercera generación cefditoreno pivoxil en el tratamiento de la infección comunitaria del adulto

    Revista Espanola de Quimioterapia, Vol. 18, Núm. 3, pp. 210-216

  5. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: A phase I, open-label, noncomparative clinical trial in healthy volunteers

    Clinical Therapeutics, Vol. 27, Núm. 7, pp. 1043-1049

2004

  1. Effects of amoxicillin subinhibitory concentrations on the cross-protection developed by pneumococcal antibodies in mouse sepsis caused by an amoxicillin-resistant serotype 6B Streptococcus pneumoniae strain

    Antimicrobial Agents and Chemotherapy, Vol. 48, Núm. 11, pp. 4144-4147

  2. In vitro combined effect of co-amoxiclav concentrations achievable in serum after a 2000/125 mg oral dose, and polymorphonuclear neutrophils against strains of Streptococcus pneumoniae exhibiting decreased susceptibility to amoxicillin

    International Journal of Antimicrobial Agents, Vol. 24, Núm. 1, pp. 79-82

  3. In vivo activity of amoxicillin/clavulanic acid and erythromycin in experimental otitis media caused by Streptococcus pneumoniae plus Haemophilus influenzae

    International Journal of Antimicrobial Agents, Vol. 23, Núm. 1, pp. 25-31

2003

  1. Does Acetaminophen Interfere in the Antibiotic Treatment of Acute Otitis Media Caused by a Penicillin-Resistant Pneumococcus Strain? A Gerbil Model

    Pediatric Research, Vol. 54, Núm. 6, pp. 913-918

  2. Efficacy and pharmacodynamics of gemifloxacin versus levofloxacin in guinea pig pneumococcal pneumonia induced by strains with decreased ciprofloxacin susceptibility

    International Journal of Antimicrobial Agents, Vol. 21, Núm. 6, pp. 568-573

  3. Estrategias para superar las resistencias de patógenos respiratorios en Atención Primaria

    Revista Espanola de Quimioterapia

  4. Is it possible to achieve bacterial eradication in otitis media with effusion by empirical antibiotic high doses and concomitant administration of acetaminophen? A microbiological and pharmacological study in the gerbil model

    International Journal of Antimicrobial Agents, Vol. 22, Núm. 5, pp. 508-515

  5. Opsonophagocytosis versus complement bactericidal killing as effectors following Neisseria meningitidis group C vaccination

    Infection, Vol. 31, Núm. 1, pp. 51-54

2002

  1. Combined eirect of specific antibodies (as serotherapy or preimmunization) and amoxicillin doses in treatment of Streptococcus pneumoniae sepsis in a mouse model [2]

    Antimicrobial Agents and Chemotherapy

  2. Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae [1]

    International Journal of Antimicrobial Agents

  3. Increase of in vitro amoxycillin bactericidal activity by clavulanic acid against Neisseria meningitis using time-kill curves [1]

    International Journal of Antimicrobial Agents